Narayana Hrudayalaya Q1 FY27 revenue up 78% to 2,684 crore

Key update from the June 2026 quarter

Narayana Hrudayalaya Limited reported a sharp year-on-year jump in consolidated operating revenue for Q1 FY27, with performance supported by domestic operations and the full-quarter integration of its UK acquisition. The quarter ended June 30, 2026, and the company said its Board reviewed and approved unaudited standalone and consolidated results at a meeting held on July 31, 2026. Consolidated operating revenue was reported at ₹2,684 crore, up about 78.1% year-on-year. The company’s official consolidated profit after tax (PAT) was reported at ₹194.05 crore, marginally lower than ₹196.10 crore in Q1 FY26. Alongside the quarterly update, the company proposed a final dividend of ₹4.50 per equity share for FY26, subject to shareholder approval.

What drove the revenue jump

The company attributed the revenue rise to robust domestic operations and the full-quarter consolidation of the UK acquisition. Q1 FY27 consolidated revenue from operations was also disclosed as ₹2,683.63 crore (₹26,836.34 million), compared with ₹1,507.27 crore (₹15,072.69 million) in Q1 FY26. This aligns with the stated year-on-year growth of approximately 78.1%. The revenue numbers were presented as consolidated “revenue from operations” and “operating revenue” in the material. In addition, segment disclosures indicated Medical and Healthcare Services revenue of ₹2,540.35 crore and Other Segment revenue of ₹156.36 crore (primarily insurance). The data also showed that the “Other” segment posted a reported loss at the segment result level.

Profit figures: official PAT vs other reported numbers

The article data includes more than one profit figure, and it flags a difference between an “official” PAT and other circulating alerts. The official consolidated PAT was stated at ₹194.05 crore for the quarter ended June 30, 2026. Separately, the consolidated net profit was also reported as ₹207.27 crore (₹2,072.70 million), up from ₹196.05 crore (₹1,960.51 million) a year earlier. A source alert referenced a consolidated net profit of ₹210 crore, which was explicitly described as not independently verified.

For standalone performance, standalone net profit was reported at ₹137.86 crore (₹1,378.55 million) for the quarter. Standalone EPS was reported at ₹6.79 (basic and diluted). The standalone income statement figures shared in the material included Revenue from Operations of ₹1,097.10 crore, EBITDA of ₹269.54 crore, profit before tax of ₹187.72 crore, and tax expense of ₹49.87 crore.

Margins, ratios, and a labour-code impact item

The quarter disclosures included margin and ratio snapshots. An operating margin of 21.80% and net profit margin of 12.57% were listed in the material. A separate set of consolidated ratios was also provided: debt-equity ratio of 1.24, interest service coverage ratio of 4.00, current ratio of 2.15, operating margin of 17.50%, and net profit margin of 7.72%.

The company also disclosed an impact of ₹45.28 crore (₹452.76 million) from implementation of new Labour Codes, described as an increase in gratuity and leave liability. The disclosure was presented as an identifiable impact item, and not as forward-looking guidance.

Discontinued operations and a business transfer

The company disclosed that the Narayana Vaishno Devi Specialty Hospitals business was transferred to Shri Mata Vaishno Devi Charitable Society effective April 1, 2026. Q1 FY27 revenue from discontinued operations was reported at ₹30.87 crore (₹308.65 million). Profit from discontinued operations was reported at ₹2.17 crore (₹21.65 million). These items were presented separately in the data, indicating a distinction in reporting between continuing and discontinued operations.

Dividend proposal and funding capacity item

The Board proposed a final dividend of ₹4.50 per equity share for FY26, subject to shareholder approval. In addition, the group indicated it plans to approve a ₹1,500 crore debt-issuance capacity at its Annual General Meeting scheduled for August 14, 2026. The debt-issuance item was described as a capacity approval rather than a confirmed immediate fundraising.

Dates to track: board approval and earnings call

The company’s Board meeting to approve the un-audited results for the quarter ended June 30, 2026 was scheduled and held on July 31, 2026, as stated in the material. An investor conference call to discuss Q1 FY27 performance was scheduled for August 3, 2026 at 3:00 PM IST. These dates matter for investors tracking management commentary, integration updates, and any additional disclosures beyond the headline financials.

Market snapshot figures mentioned

The material included a market snapshot with the stock’s current market context. One snapshot listed market capitalisation at ₹41,961.8 crore and a current market price (CMP) of ₹2,054.0. Another line cited a market cap of ₹37,625 crore and a P/E of 45.6, presented as a separate source snapshot. The article data also included prior quarter reference numbers in millions, listing “previous quarter revenue” at ₹2,593.80 crore (₹25,938 million) and “previous quarter PAT” at ₹224.00 crore (₹2,240 million).

Key numbers table

Why the update matters for investors

The quarter highlights show a step-change in consolidated revenue, with the UK acquisition’s full-quarter integration cited as a driver alongside domestic operations. At the same time, the profit discussion requires careful reading because the material includes multiple profit figures, including an “official” consolidated PAT of ₹194.05 crore and a separate consolidated net profit figure of ₹207.27 crore. For investors, the scheduled earnings call on August 3, 2026 is a key event to track for clarity on integration, segment performance, and any reconciliation of headline versus detailed profit metrics.

Narayana Hrudayalaya also signalled shareholder actions ahead, including the FY26 final dividend proposal and the planned AGM approval for debt-issuance capacity. The next set of formal milestones in the disclosed schedule are the August 3 investor call and the August 14, 2026 AGM agenda item on funding capacity.